β-Catenin as a multilayer modulator of zonal cytochrome P450 expression in mouse liver

被引:3
|
作者
Braeuning, Albert [1 ]
Schwarz, Michael [1 ]
机构
[1] Univ Tubingen, Dept Toxicol, Inst Expt & Clin Pharmacol & Toxicol, D-72074 Tubingen, Germany
关键词
beta-catenin; cytochrome P450; drug metabolism; enzyme induction; hepatic zonation; transcriptional regulation; ARYL-HYDROCARBON RECEPTOR; DRUG-METABOLIZING-ENZYMES; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; GLUTAMINE-SYNTHETASE; TUMOR PROMOTION; HA-RAS; PATHWAY; WNT; ZONATION;
D O I
10.1515/BC.2010.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The liver is the major organ for metabolism of drugs and other xenobiotics. Expression of many drug-metabolizing enzymes is not equally distributed throughout the liver: under normal conditions, many of them, including the most relevant members of the cytochrome P450 superfamily, are exclusively expressed in a hepatocyte subpopulation located near branches of the efferent central vein. Activation of different ligand-dependent transcription factors by exogenous compounds stimulates high expression of certain cytochrome P450 isoforms. This process also occurs preferentially in perivenous hepatocytes. The mechanisms, however, which determine the zone-specificity of basal and xenobiotic-induced expression of cytochrome P450 enzymes, have remained largely unknown for decades. Very recently, signaling through the Wnt/beta-catenin pathway has been implicated in the regulation of zonal gene expression in mouse liver. In this review, current knowledge of cytochrome P450 regulation by beta-catenin-dependent transcription is summarized and underlying molecular mechanisms are discussed.
引用
收藏
页码:139 / 148
页数:10
相关论文
共 50 条
  • [31] Effects of tetrahydroxystilbene glucoside on mouse liver cytochrome P450 enzyme expressions
    Wang, Yan-Ying
    Yang, Jun
    Liu, Hang
    Lin, Feng-Qin
    Shi, Jing-Shan
    Zhang, Feng
    XENOBIOTICA, 2015, 45 (04) : 279 - 285
  • [32] Liver-specific loss of β-catenin blocks glutamine synthesis pathway activity and cytochrome P450 expression in mice
    Sekine, S
    Lan, BYA
    Bedolli, M
    Feng, S
    Hebrok, M
    HEPATOLOGY, 2006, 43 (04) : 817 - 825
  • [33] Expression of cytochrome P450 in lung tumor
    Gharavi, N
    El-Kadi, AOS
    CURRENT DRUG METABOLISM, 2004, 5 (02) : 203 - 210
  • [34] Comparative expression profiling of the mouse cytochrome P450 gene family.
    Stoilov, I
    Choudhary, D
    Jansson, I
    Schenkman, JB
    Sarfarazi, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 243 - 243
  • [35] Expression and characterisation of cytochrome P450 BioI
    Green, AJ
    Rivers, SL
    Munro, AW
    Chapman, SK
    Reid, GA
    JOURNAL OF INORGANIC BIOCHEMISTRY, 1999, 74 (1-4) : 147 - 147
  • [36] Regulation of cytochrome P450 expression by sphingolipids
    Merrill, AH
    Nikolova-Karakashian, M
    Schmelz, EM
    Morgan, ET
    Stewart, J
    CHEMISTRY AND PHYSICS OF LIPIDS, 1999, 102 (1-2) : 131 - 139
  • [37] Measurement of cytochrome P450 and NADPH–cytochrome P450 reductase
    F Peter Guengerich
    Martha V Martin
    Christal D Sohl
    Qian Cheng
    Nature Protocols, 2009, 4 : 1245 - 1251
  • [38] Cytochrome P450 expression and regulation in the brain
    Kuban, Wojciech
    Daniel, Wladyslawa Anna
    DRUG METABOLISM REVIEWS, 2021, 53 (01) : 1 - 29
  • [40] The role of brain noradrenergic system in the regulation of liver cytochrome P450 expression
    Sadakierska-Chudy, Anna
    Haduch, Anna
    Rysz, Marta
    Golembiowska, Krystyna
    Daniel, Wladyslawa A.
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (06) : 800 - 807